Nantahala Capital Management
Latest statistics and disclosures from Nantahala Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IWM, ESTA, QURE, APEN, IMAX, and represent 41.85% of Nantahala Capital Management's stock portfolio.
- Added to shares of these 10 stocks: CVT (+$7.1M), APEN (+$5.1M), EHTH (+$5.1M), CRMT, ESTA, ILPT, UTHR, VKTX, ABEO, JSPR.
- Started 19 new stock positions in Structure Therapeutics, EHTH, KRE, SRTS, CVT, VKTX, Lucy Scientific Discovery In, ILPT, EBET, JSPR. AMRX, DYN, LFCR, EAR, UTHR, SCYX, GAIA, SELB, Aytu Biopharma.
- Reduced shares in these 10 stocks: IWM (-$212M), TA (-$38M), IMAX (-$32M), Paya Holdings Inc-a (-$19M), Concert Pharmaceuticals I equity (-$10M), AMYT (-$9.0M), ALTG (-$8.9M), QURE (-$8.7M), PRDO (-$7.0M), PTON (-$6.0M).
- Sold out of its positions in Concert Pharmaceuticals I equity, DSHK, IDN, KTRA, LQDA, NAUT, Paya Holdings Inc-a, PRDO, Shift Technologi, SGU. VRM, Weber Inc Cl A, Ftac Hera Aquisistion Corp, CYRNQ.
- Nantahala Capital Management was a net seller of stock by $-313M.
- Nantahala Capital Management has $1.3B in assets under management (AUM), dropping by -15.42%.
- Central Index Key (CIK): 0001472322
Tip: Access up to 7 years of quarterly data
Positions held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nantahala Capital Management
Nantahala Capital Management holds 115 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr Russell 2000 Etf (IWM) | 16.4 | $214M | -49% | 1.2M | 178.40 |
|
| Establishment Labs Holdings Ord (ESTA) | 10.2 | $134M | +2% | 2.0M | 67.74 |
|
| Uniqure Nv SHS (QURE) | 5.3 | $70M | -11% | 3.5M | 20.14 |
|
| Apollo Endosurgery (APEN) | 5.0 | $65M | +8% | 6.6M | 9.92 |
|
| Imax Corp Cad (IMAX) | 4.9 | $63M | -33% | 3.3M | 19.18 |
|
| Meta Financial (CASH) | 4.3 | $56M | +2% | 1.3M | 41.49 |
|
| Travelcenters Of America Com New (TA) | 4.0 | $52M | -41% | 598k | 86.50 |
|
| Luxfer Hldgs SHS (LXFR) | 3.2 | $42M | 2.5M | 16.90 |
|
|
| Peloton Interactive Cl A Com (PTON) | 2.8 | $37M | -13% | 3.2M | 11.34 |
|
| Keros Therapeutics (KROS) | 2.5 | $32M | -9% | 755k | 42.70 |
|
| Travel Leisure Ord (TNL) | 1.9 | $25M | 629k | 39.20 |
|
|
| Red Violet (RDVT) | 1.8 | $23M | +2% | 1.3M | 17.60 |
|
| Rmr Group Cl A (RMR) | 1.7 | $22M | -2% | 822k | 26.24 |
|
| Codexis (CDXS) | 1.6 | $21M | +14% | 5.2M | 4.14 |
|
Setup an alertNantahala Capital Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Syndax Pharmaceuticals (SNDX) | 1.6 | $21M | 976k | 21.12 |
|
|
| Herman Miller (MLKN) | 1.5 | $19M | -6% | 934k | 20.45 |
|
| Immatics SHS (IMTX) | 1.5 | $19M | 2.7M | 6.90 |
|
|
| Rh (RH) | 1.4 | $19M | +10% | 76k | 243.55 |
|
| Hilton Grand Vacations (HGV) | 1.4 | $18M | 410k | 44.43 |
|
|
| Mediaalpha Cl A (MAX) | 1.2 | $16M | -15% | 1.1M | 14.98 |
|
| Cymabay Therapeutics (CBAY) | 1.2 | $16M | -20% | 1.8M | 8.72 |
|
| Viemed Healthcare (VMD) | 1.2 | $15M | -10% | 1.6M | 9.66 |
|
| Golden Entmt (GDEN) | 1.2 | $15M | -22% | 353k | 43.51 |
|
| Autolus Therapeutics Spon Ads (AUTL) | 1.1 | $14M | 7.7M | 1.84 |
|
|
| Dhi (DHX) | 1.0 | $13M | -6% | 3.4M | 3.88 |
|
| Amryt Pharma Sponsored Ads (AMYT) | 0.9 | $12M | -42% | 821k | 14.58 |
|
| Dariohealth Corp Com New (DRIO) | 0.8 | $10M | 2.4M | 4.12 |
|
|
| Alta Equipment Group Common Stock (ALTG) | 0.8 | $9.9M | -47% | 627k | 15.85 |
|
| Herbalife Nutrition Com Shs Call Option (HLF) | 0.7 | $9.7M | -30% | 600k | 16.10 |
|
| Payoneer Global (PAYO) | 0.7 | $9.5M | +39% | 1.5M | 6.28 |
|
| Rumbleon Com Cl B (RMBL) | 0.7 | $9.5M | +5% | 1.6M | 6.06 |
|
| Reading Intl Cl A (RDI) | 0.7 | $9.4M | 2.9M | 3.25 |
|
|
| Dxp Enterprises Com New (DXPE) | 0.7 | $9.1M | 338k | 26.92 |
|
|
| Aura Biosciences (AURA) | 0.6 | $7.8M | +5% | 843k | 9.28 |
|
| Zoom Video Communications In Cl A Call Option (ZM) | 0.6 | $7.4M | 100k | 73.84 |
|
|
| Diversified Healthcare Tr Com Sh Ben Int (DHC) | 0.6 | $7.3M | +27% | 5.4M | 1.35 |
|
| Cvent Holding Corp Common Stock (CVT) | 0.5 | $7.1M | NEW | 845k | 8.36 |
|
| Ventyx Biosciences (VTYX) | 0.5 | $6.5M | +21% | 193k | 33.50 |
|
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.5 | $6.0M | +8% | 4.7M | 1.27 |
|
| Fortress Biotech (FBIO) | 0.4 | $5.7M | -13% | 6.9M | 0.82 |
|
| Bioventus Com Cl A (BVS) | 0.4 | $5.5M | +63% | 5.2M | 1.07 |
|
| MiMedx (MDXG) | 0.4 | $5.2M | +33% | 1.5M | 3.41 |
|
| eHealth (EHTH) | 0.4 | $5.1M | NEW | 549k | 9.36 |
|
| America's Car-Mart (CRMT) | 0.4 | $5.1M | +327% | 64k | 79.21 |
|
| Strata Skin Sciences Com New (SSKN) | 0.4 | $4.7M | 4.4M | 1.06 |
|
|
| Perella Weinberg Partners Class A Com (PWP) | 0.4 | $4.6M | +110% | 505k | 9.10 |
|
| Lyra Therapeutics (LYRA) | 0.3 | $4.5M | 2.2M | 2.01 |
|
|
| Ringcentral Cl A (RNG) | 0.3 | $4.2M | 138k | 30.67 |
|
|
| Point Biopharma Global (PNT) | 0.3 | $4.2M | 572k | 7.27 |
|
|
| Par Technology Corp Note 2.875% 4/1 (Principal) | 0.3 | $4.0M | 3.8M | 1.07 |
|
|
| Abeona Therapeutics Com New (ABEO) | 0.3 | $4.0M | +423% | 1.4M | 2.82 |
|
| Industrial Logistics Pptys T Com Shs Ben Int (ILPT) | 0.3 | $3.9M | NEW | 1.3M | 3.07 |
|
| Playags (AGS) | 0.3 | $3.6M | +123% | 497k | 7.15 |
|
| United Therapeutics Corporation (UTHR) | 0.3 | $3.5M | NEW | 16k | 223.96 |
|
| Ideaya Biosciences (IDYA) | 0.3 | $3.5M | 254k | 13.73 |
|
|
| Viking Therapeutics (VKTX) | 0.3 | $3.3M | NEW | 201k | 16.65 |
|
| Aptose Biosciences Com New (APTO) | 0.2 | $3.2M | -17% | 5.0M | 0.64 |
|
| Medifast (MED) | 0.2 | $3.1M | 30k | 103.67 |
|
|
| Jasper Therapeutics (JSPR) | 0.2 | $3.1M | NEW | 1.7M | 1.81 |
|
| Optinose (OPTN) | 0.2 | $2.8M | 1.5M | 1.93 |
|
|
| The Aarons Company (AAN) | 0.2 | $2.8M | 289k | 9.66 |
|
|
| Tela Bio (TELA) | 0.2 | $2.7M | -26% | 256k | 10.64 |
|
| Enova Intl (ENVA) | 0.2 | $2.4M | 53k | 44.43 |
|
|
| Merrimack Pharmaceuticals In Com New (MACK) | 0.2 | $2.4M | -8% | 191k | 12.29 |
|
| Spdr Ser Tr S&p Regl Bkg Call Option (KRE) | 0.2 | $2.2M | NEW | 50k | 43.86 |
|
| Scully Royalty Com Shs (SRL) | 0.2 | $2.1M | 311k | 6.70 |
|
|
| Dyne Therapeutics (DYN) | 0.2 | $2.1M | NEW | 179k | 11.52 |
|
| Neuropace (NPCE) | 0.2 | $2.0M | 426k | 4.64 |
|
|
| Aerovate Therapeutics (AVTE) | 0.1 | $1.9M | +505% | 95k | 20.17 |
|
| Disc Medicine (IRON) | 0.1 | $1.9M | -44% | 90k | 21.19 |
|
| B. Riley Financial (RILY) | 0.1 | $1.8M | -8% | 63k | 28.39 |
|
| Daktronics (DAKT) | 0.1 | $1.7M | 292k | 5.67 |
|
|
| Adc Therapeutics Sa SHS (ADCT) | 0.1 | $1.6M | +245% | 840k | 1.95 |
|
| Soleno Therapeutics (SLNO) | 0.1 | $1.5M | +15% | 699k | 2.14 |
|
| Anebulo Pharmaceuticals (ANEB) | 0.1 | $1.5M | 511k | 2.90 |
|
|
| Rezolute Com New (RZLT) | 0.1 | $1.5M | +7% | 770k | 1.92 |
|
| Carvana Cl A Call Option (CVNA) | 0.1 | $1.5M | 150k | 9.79 |
|
|
| Immatics *w Exp 07/01/202 (IMTXW) | 0.1 | $1.4M | 986k | 1.44 |
|
|
| Avalo Therapeutics Com New (AVTX) | 0.1 | $1.4M | +49% | 809k | 1.75 |
|
| Selecta Biosciences (SELB) | 0.1 | $1.4M | NEW | 1.0M | 1.39 |
|
| Unicycive Therapeutics (UNCY) | 0.1 | $1.4M | 647k | 2.10 |
|
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $1.4M | -42% | 1.7M | 0.78 |
|
| Aeglea Biotherapeutics (AGLE) | 0.1 | $1.3M | 4.6M | 0.29 |
|
|
| Akumin (AKU) | 0.1 | $1.3M | -14% | 1.9M | 0.68 |
|
| Wabash National Corporation Put Option (WNC) | 0.1 | $1.2M | -25% | 50k | 24.59 |
|
| Structure Therapeutics Sponsored Ads | 0.1 | $1.2M | NEW | 50k | 23.79 |
|
| Cytokinetics Com New (CYTK) | 0.1 | $1.1M | +524% | 30k | 35.19 |
|
| Sensus Healthcare (SRTS) | 0.1 | $964k | NEW | 185k | 5.21 |
|
| Acer Therapeutics (ACER) | 0.1 | $913k | 1.2M | 0.76 |
|
|
| Scynexis Com New (SCYX) | 0.1 | $900k | NEW | 300k | 3.00 |
|
| Spar (SGRP) | 0.1 | $899k | +29% | 697k | 1.29 |
|
| Landec Corporation (LFCR) | 0.1 | $735k | NEW | 195k | 3.77 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.1 | $695k | NEW | 500k | 1.39 |
|
| Aytu Biopharma | 0.0 | $608k | NEW | 272k | 2.24 |
|
| Idw Media Hldgs CL B (IDW) | 0.0 | $592k | 823k | 0.72 |
|
|
| Angion Biomedica Corp (ANGN) | 0.0 | $541k | -4% | 983k | 0.55 |
|
| Hyperfine Com Cl A (HYPR) | 0.0 | $531k | -32% | 368k | 1.44 |
|
| Ebet (EBET) | 0.0 | $438k | NEW | 1.1M | 0.41 |
|
| Lucid Diagnostics (LUCD) | 0.0 | $377k | -6% | 262k | 1.44 |
|
| TransAct Technologies Incorporated (TACT) | 0.0 | $376k | -7% | 61k | 6.19 |
|
| Journey Med Corp (DERM) | 0.0 | $333k | -6% | 212k | 1.57 |
|
| Cue Biopharma (CUE) | 0.0 | $333k | 93k | 3.57 |
|
|
| Exagen (XGN) | 0.0 | $322k | -9% | 133k | 2.43 |
|
| Bm Technologies Cl A Com (BMTX) | 0.0 | $279k | -74% | 79k | 3.52 |
|
| Eargo Com New (EAR) | 0.0 | $253k | NEW | 54k | 4.68 |
|
| Imac Hldgs (BACK) | 0.0 | $149k | -11% | 1.0M | 0.14 |
|
| Curis Com New (CRIS) | 0.0 | $137k | -71% | 231k | 0.60 |
|
| Rafael Hldgs Com Cl B (RFL) | 0.0 | $113k | 73k | 1.55 |
|
|
| Lucy Scientific Discovery In | 0.0 | $105k | NEW | 96k | 1.10 |
|
| Gaia Cl A (GAIA) | 0.0 | $64k | NEW | 23k | 2.78 |
|
| Fulcrum Therapeutics (FULC) | 0.0 | $61k | -95% | 21k | 2.85 |
|
| Catalyst Biosciences Com New (CBIO) | 0.0 | $33k | -63% | 160k | 0.21 |
|
| Guardforce Ai *w Exp 10/01/202 (GFAIW) | 0.0 | $31k | 154k | 0.20 |
|
|
| Tc Biopharm Holdings *w Exp 02/08/202 (TCBPW) | 0.0 | $24k | 235k | 0.10 |
|
|
| Qualtek Services *w Exp 02/14/202 (QTEKW) | 0.0 | $2.9k | 96k | 0.03 |
|
|
Past Filings by Nantahala Capital Management
SEC 13F filings are viewable for Nantahala Capital Management going back to 2011
- Nantahala Capital Management 2023 Q1 filed May 15, 2023
- Nantahala Capital Management 2022 Q4 filed Feb. 14, 2023
- Nantahala Capital Management 2022 Q3 filed Nov. 10, 2022
- Nantahala Capital Management 2022 Q2 filed Aug. 15, 2022
- Nantahala Capital Management 2022 Q1 filed May 13, 2022
- Nantahala Capital Management 2021 Q4 filed Feb. 14, 2022
- Nantahala Capital Management 2021 Q3 filed Nov. 15, 2021
- Nantahala Capital Management 2021 Q2 filed Aug. 16, 2021
- Nantahala Capital Management 2021 Q1 filed May 14, 2021
- Nantahala Capital Management 2020 Q4 filed Feb. 16, 2021
- Nantahala Capital Management 2020 Q3 filed Nov. 16, 2020
- Nantahala Capital Management 2020 Q2 filed Aug. 14, 2020
- Nantahala Capital Management 2020 Q1 filed May 14, 2020
- Nantahala Capital Management 2019 Q4 filed Feb. 14, 2020
- Nantahala Capital Management 2019 Q3 filed Nov. 14, 2019
- Nantahala Capital Management 2019 Q2 filed Aug. 14, 2019